In August 2019, Botanix completed a A$40m US-led institutional placement. The funds from the
placement enables Botanix to execute its key clinical development programmes and accelerate its
broader commercialisation strategy. The Company is also expecting to receive approximately A$7m
in R&D tax incentive in 4Q CY2019. Botanix is now fully funded to progress the development of its
rosacea and antimicrobial programs into the clinic and undertake supportive studies required prior to
commencement of Phase 3 studies for BTX 1503.
Looking Forward to a GREAT 2020, page-8
-
- There are more pages in this discussion • 779 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
41.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $752.8M | |||
| Open | High | Low | Value | Volume |
| 41.0¢ | 43.5¢ | 41.0¢ | $2.989M | 7.071M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 408524 | 41.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.0¢ | 30000 | 1 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |